Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Opinion in Rheumatology|August 1, 2009
B cell depletion in lupus and Sjögren's syndrome: an updateAndreea Coca, Ignacio Sanz
Current Opinion in Rheumatology|August 9, 2012
Updates on B-cell immunotherapies for systemic lupus erythematosus and Sjogren's syndromeAndreea Coca, Iñaki Sanz
F1000 Medicine Reports|October 16, 2010
Two negative randomized controlled trials in lupus: now what?Andreea Coca, Jennifer H Anolik
Clinical Reviews in Allergy & Immunology|January 9, 2008
Targeted biologic approaches to the treatment of systemic vasculitisAndreea Coca, Jennifer H Anolik
Clinical Immunology (Orlando, Fla.)|March 20, 2009
Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulinAndreea Coca, Kemp W Bundy, Bethany Marston, et al.
Biomedicines|September 27, 2025
Hemodynamic and Clinical Predictors of Thrombolysis in Post-COVID Venous Thromboembolism: A Retrospective Cohort StudyGiulia-Mihaela Cojocaru, Antoniu Octavian Petriş, Alin-Constantin Pînzariu, et al.
Proteomics|August 14, 2012
Quantitative proteomics of parotid saliva in primary Sjögren's syndromeKiran S Ambatipudi, Stephen Swatkoski, James J Moresco, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 10, 2014
Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cellsMustimbo E P Roberts, Denise Kaminski, Scott A Jenks, et al.
Pageof 2